Financhill
Sell
40

ELV Quote, Financials, Valuation and Earnings

Last price:
$343.53
Seasonality move :
10.44%
Day range:
$341.72 - $345.33
52-week range:
$273.71 - $458.75
Dividend yield:
1.99%
P/E ratio:
14.04x
P/S ratio:
0.40x
P/B ratio:
1.74x
Volume:
806.4K
Avg. volume:
1.7M
1-year change:
-7.46%
Market cap:
$76.3B
Revenue:
$176.8B
EPS (TTM):
$24.45

Earnings Data

Next earnings date for ELV
Jan 28
2026
Most recent earnings per share
$5.32
Beat by $0.37
(Oct 21/2025)
Consensus Estimate
$4.94
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ELV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/28/2026 Q4 $49.5B -- -- $3.15 --
10/21/2025 Q3 $49.5B $50.7B $5.32 $4.94 $0.37
07/17/2025 Q2 $48.2B $49.8B $7.72 $8.96 -$1.25
04/22/2025 Q1 $46.2B $48.9B $9.61 $11.48 -$1.87
01/23/2025 Q4 $44.7B $45.4B $1.81 $3.85 -$2.04
10/17/2024 Q3 $43.1B $45.1B $4.36 $9.65 -$5.29
07/17/2024 Q2 $42.9B $43.6B $9.85 $10.01 -$0.15
04/18/2024 Q1 $42.4B $42.6B $9.59 $10.53 -$0.94
01/24/2024 Q4 $42.2B $42.6B $3.63 $5.59 -$1.96
10/18/2023 Q3 -- $42.8B $5.45 -- --
07/19/2023 Q2 -- $43.7B $7.79 -- --
04/19/2023 Q1 -- $42.2B $8.30 -- --
01/25/2023 Q4 -- $39.9B $3.59 -- --
10/19/2022 Q3 -- $39.9B $6.62 -- --
07/20/2022 Q2 -- $38.6B $6.73 -- --
04/20/2022 Q1 -- $38.1B $7.32 -- --
12/31/2021 Q4 -- $36.6B $4.63 -- --
09/30/2021 Q3 -- $35.8B $6.13 -- --
06/30/2021 Q2 -- $33.9B $7.25 -- --
03/31/2021 Q1 -- $32.4B $6.71 -- --
12/31/2020 Q4 -- $31.8B $2.19 -- --
09/30/2020 Q3 -- $31.2B $0.87 -- --
06/30/2020 Q2 -- $29.3B $8.91 -- --
03/31/2020 Q1 -- $29.6B $5.94 -- --
12/31/2019 Q4 -- $27.4B $3.62 -- --
09/30/2019 Q3 -- $26.7B $4.55 -- --
06/30/2019 Q2 -- $25.5B $4.36 -- --
03/31/2019 Q1 -- $24.7B $5.91 -- --
12/31/2018 Q4 -- $23.4B $1.61 -- --
09/30/2018 Q3 -- $23.3B $3.62 -- --
06/30/2018 Q2 -- $22.9B $3.98 -- --
03/31/2018 Q1 -- $22.5B $4.99 -- --
12/31/2017 Q4 -- $22.7B $4.67 -- --
09/30/2017 Q3 -- $22.4B $2.80 -- --
06/30/2017 Q2 -- $22.4B $3.16 -- --
03/31/2017 Q1 -- $22.5B $3.73 -- --
12/31/2016 Q4 -- $21.7B $1.37 -- --
09/30/2016 Q3 -- $21.4B $2.30 -- --
06/30/2016 Q2 -- $21.5B $2.91 -- --
03/31/2016 Q1 -- $20.4B $2.63 -- --
12/31/2015 Q4 -- $20.2B $0.68 -- --

Elevance Health, Inc. Earnings Questions

  • How Much did Elevance Health, Inc. Generate in Revenue Last Quarter?

    Elevance Health, Inc. reported $50.7B worth of top line sales in its most recent quarter.

  • Did Elevance Health, Inc. Beat Earnings Last Quarter?

    Elevance Health, Inc. announced earnings per share of $5.32 which represents a beat of analyst forecast a $4.94 per share.

  • Is Elevance Health, Inc. Profitable?

    Elevance Health, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Elevance Health, Inc. EPS Next Year?

    Elevance Health, Inc.'s earnings are forecast to grow from $25.68 per share to $32.96 per share next year representing an increase of 16.79%.

  • When is Elevance Health, Inc.'s Earnings Date?

    Elevance Health, Inc.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock